In order to provide an overview for busy in-house counsel and compliance professionals, we summarize below some of the most important SEC enforcement developments from the past month.
/PRNewswire/ Today, the U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of.
The British authorities said Merck’s molnupiravir was “safe and effective” in reducing the risk of hospitalization and death for those at increased risk of severe symptoms.